CHMP recommends EU approval of Actemra/RoActemra to treat patients with severe COVID-19
Actemra/RoActemra reduced the risk of death in patients with severe COVID-19, as evidenced by a review of four phase-III studies.…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Dr Jyotsna Dhawan joins DBT/India Alliance as CEO
She has taken over responsibilities from Dr Vasan Sambandamurthy with effect from 1st December, 2021 till further communication
Aurobindo and Unichem recall products in US market
The affected lot contains 6.25 mg Carvedilol tablets, which have been produced in India and distributed in the US by…
Omicron: Parliamentary panel recommends evaluation of vaccines, more research for booster dose
The Parliamentary Standing Committee on Health, which presented its report recently, also said that concerns with regard to the…
US FDA adds strict safety warnings on arthritis drugs from Pfizer, AbbVie and Lilly
The US Food and Drug Administration's boxed warnings on the labels of Rinvoq , Xeljanz and Olumiant flags the risk of…
Vaccine makers could make Omicron-specific booster, says Fauci
The US government is working with Moderna, Pfizer and J&J on multiple contingency plans, infectious disease expert Anthony…
Covishield current monthly production capacity 250-275 million doses, Covaxin 50-60 million doses,…
Both companies have achieved close to 90 per cent of present production capacity, Bharati Pravin Pawar, Minister of State for…
Eris Lifesciences announces Joint Venture with MJ Biopharm to offer insulin in India
The 70:30 Joint Venture will primarily engage in marketing and distribution of human and analogue insulin including Aspart,…
FDA expands authorisation of two monoclonal antibodies for treatment and post-exposure prevention…
Amlanivimab and Etesevimab are monoclonal antibodies that are specifically directed against the spike protein of SARS-CoV-2,…
Pharma industry reports 53 deals worth $9.6 billion in November 2021: GlobalData
The industry reported 105 venture capital (VC) deals worth $4.2 billion in November 2021, compared to the last 12-month average…
SPARC enters into licensing agreement with Biomodifying to acquire exclusive rights for antibody…
Under the agreement, Biomodifying is eligible for an upfront payment, milestone payments on pre-specified clinical, regulatory,…
Coping and thriving through COVID-19
As 2021 is about to end, a few stakeholders from the pharma industry share some key lessons learnt in the past year
Morepen gets US FDA approval for Fexofinadine
Fexofinadine is the most widely used, second-generation antihistamine drug for the treatment of allergy symptoms and hay fever
10th Indian Pharma Expo to be held from 10-11 December in Delhi
IPE offers opportunities for the participating companies to meet, showcase and promote their products and services to visitors…
GSK and Oxford University announce Oxford-GSK Institute of Molecular and Computational Medicine
The institute aims to improve the success and speed of research and development of new medicines, building on insights from human…
UK study finds mRNA COVID-19 vaccines provide biggest booster impact
The study found that six out of the seven boosters examined enhanced immunity after initial vaccination with Pfizer-BioNTech's…
Amgen announces positive top-line results from Otezla phase-III Discreet study in moderate-to-severe…
Otezla resulted in clinically and statistically significant improvements in measures of genital psoriasis at week 16 compared with…
Novavax says it could start making Omicron-specific vaccine in January
Other vaccine makers including Moderna and Pfizer have also begun working on Omicron-tailored COVID-19 shots
Biocon gets US FDA nod for generic product
The product is indicated for the prophylaxis of organ rejection in adult patients receiving a kidney transplant and is available…
Moderna COVID vaccine highly effective five months after second dose: Study
Funded by Moderna, the study included 352,878 recipients of two doses of the vaccine matched to 352,878 unvaccinated individuals…